CLINICAL RESEARCH: HEART FAILURE
Clinical Presentation, Management, and In-Hospital Outcomes of Patients Admitted With Acute Decompensated Heart Failure With Preserved Systolic Function
A Report From the Acute Decompensated Heart Failure National Registry (ADHERE) Database
Clyde W. Yancy, MD, FACC*,*,
Margarita Lopatin, MS ,
Lynne Warner Stevenson, MD, FACC ,
Teresa De Marco, MD, FACC ,
Gregg C. Fonarow, MD, FACC|| for the ADHERE Scientific Advisory Committee and Investigators
* Division of Cardiology, Department of Medicine, University of Texas Southwest Medical Center, Dallas, Texas
Department of Biostatistics, Scios Inc., Fremont, California
Cardiovascular Division, Brigham and Women’s Hospital, Boston, Massachusetts
Division of Cardiology, Department of Medicine, University of California, San Francisco, San Francisco, California
|| Ahmanson-UCLA Cardiomyopathy Center, UCLA Medical Center, Los Angeles, California
Manuscript received March 25, 2005;
revised manuscript received August 17, 2005,
accepted September 8, 2005.
* Reprint requests and correspondence: Dr. Clyde W. Yancy, University of Texas Southwest Medical Center, 5323 Harry Hines Boulevard, Dallas, Texas 75390-9047. (Email: Clyde.Yancy{at}UTSouthwestern.edu).
OBJECTIVES: The aims of this analysis were to describe the clinical characteristics, management, and outcomes of patients hospitalized for acute decompensated heart failure (HF) with preserved systolic function (PSF).
BACKGROUND: Clinically meaningful characteristics of these patients have not been fully studied in a large database.
METHODS: Data from >100,000 hospitalizations from the Acute Decompensated Heart Failure National Registry (ADHERE) database were analyzed.
RESULTS: Heart failure with PSF was present in 50.4% of patients with in-hospital assessment of left ventricular function. When compared with patients with systolic dysfunction, patients with PSF were more likely to be older, women, and hypertensive and less likely to have had a prior myocardial infarction or be receiving an angiotensin-converting enzyme inhibitor or angiotensin II receptor blocker. In-hospital mortality was lower in patients with PSF compared with patients with systolic dysfunction (2.8% vs. 3.9%; adjusted odds ratio [OR]: 0.86; p = 0.005), but duration of intensive care unit stay and total hospital length of stay were similar. Serum creatinine >2 mg/dl was associated with increased in-hospital mortality in both systolic function groups (PSF: 4.8%; systolic dysfunction: 8.4%; p < 0.0001), and the most powerful predictors of in-hospital mortality in both groups were blood urea nitrogen >37 mg/dl (OR: 2.53; 95% confidence interval [CI]: 2.22 to 2.87) and systolic blood pressure  125 mm Hg (OR: 2.58; 95% CI: 2.33 to 2.86).
CONCLUSIONS: Heart failure with PSF is common and is characterized by a unique patient profile. Event rates are worrisome and reflect a need for more effective management strategies.
|
Abbreviations and Acronyms
| | ACE = angiotensin-converting enzyme | | ADHERE = Acute Decompensated Heart Failure National Registry | | ARB = angiotensin II receptor blocker | | BP = blood pressure | | BUN = blood urea nitrogen | | CART = classification and regression tree | | CI = confidence interval | | HF = heart failure | | LV = left ventricular | | OR = odds ratio | | PSF = preserved systolic function |
|
This article has been cited by other articles:
|
|
|
|
 
P. Ray, S. Delerme, P. Jourdain, and C. Chenevier-Gobeaux
Differential diagnosis of acute dyspnea: the value of B natriuretic peptides in the emergency department
QJM,
November 1, 2008;
101(11):
831 - 843.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Authors/Task Force Members, K. Dickstein, A. Cohen-Solal, G. Filippatos, J. J.V. McMurray, P. Ponikowski, P. A. Poole-Wilson, A. Stromberg, D. J. van Veldhuisen, D. Atar, et al.
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM)
Eur. Heart J.,
October 1, 2008;
29(19):
2388 - 2442.
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Bukowska, U. Lendeckel, A. Krohn, G. Keilhoff, S. t. Have, K. H. Neumann, and A. Goette
Atrial fibrillation down-regulates renal neutral endopeptidase expression and induces profibrotic pathways in the kidney
Europace,
October 1, 2008;
10(10):
1212 - 1217.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. R. Di Tullio
Diastolic Dysfunction: Does Ethnicity Matter?
J. Am. Coll. Cardiol.,
September 16, 2008;
52(12):
1022 - 1023.
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. Lombardo, T. V Bridgeman, N. De Michelis, and M. Nunez
An academic medical centre's programme to develop clinical pathways to manage health care: focus on acute decompensated heart failure
J Integr Care Pathw,
September 1, 2008;
12(2):
45 - 55.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. S. Maisel, W. F. Peacock, N. McMullin, R. Jessie, G. C. Fonarow, J. Wynne, and R. M. Mills
Timing of Immunoreactive B-Type Natriuretic Peptide Levels and Treatment Delay in Acute Decompensated Heart Failure: An ADHERE (Acute Decompensated Heart Failure National Registry) Analysis
J. Am. Coll. Cardiol.,
August 12, 2008;
52(7):
534 - 540.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. J. Shah and M. Gheorghiade
Heart Failure With Preserved Ejection Fraction: Treat Now by Treating Comorbidities
JAMA,
July 23, 2008;
300(4):
431 - 433.
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. W. Stevenson
Challenges for the Basis of Practice in Heart Failure
Circ Heart Fail,
May 1, 2008;
1(1):
81 - 83.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Dhar, D. Koul, and G. E. D'Alonzo Jr
Current Concepts in Diastolic Heart Failure
J Am Osteopath Assoc,
April 1, 2008;
108(4):
203 - 209.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
F. Zannad, W. G. Stough, B. Pitt, J. G.F. Cleland, K. F. Adams, N. L. Geller, C. Torp-Pedersen, B.-A. Kirwan, and F. Follath
Heart failure as an endpoint in heart failure and non-heart failure cardiovascular clinical trials: the need for a consensus definition
Eur. Heart J.,
February 1, 2008;
29(3):
413 - 421.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. M. Givertz, B. M. Massie, T. K. Fields, L. L. Pearson, H. C. Dittrich, and on behalf of the CKI-201 and CKI-202 Investigators
The Effects of KW-3902, an Adenosine A1-Receptor Antagonist,on Diuresis and Renal Function in Patients With Acute Decompensated Heart Failure and Renal Impairment or Diuretic Resistance
J. Am. Coll. Cardiol.,
October 16, 2007;
50(16):
1551 - 1560.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
W. J. Paulus, C. Tschope, J. E. Sanderson, C. Rusconi, F. A. Flachskampf, F. E. Rademakers, P. Marino, O. A. Smiseth, G. De Keulenaer, A. F. Leite-Moreira, et al.
How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology
Eur. Heart J.,
October 2, 2007;
28(20):
2539 - 2550.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
F. L. Martin, T. Supaporn, H. H. Chen, S. M. Sandberg, Y. Matsuda, M. Jougasaki, and J. C. Burnett Jr.
Distinct roles for renal particulate and soluble guanylyl cyclases in preserving renal function in experimental acute heart failure
Am J Physiol Regulatory Integrative Comp Physiol,
October 1, 2007;
293(4):
R1580 - R1585.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. C. Fonarow, W. G. Stough, W. T. Abraham, N. M. Albert, M. Gheorghiade, B. H. Greenberg, C. M. O'Connor, J. L. Sun, C. W. Yancy, J. B. Young, et al.
Characteristics, Treatments, and Outcomes of Patients With Preserved Systolic Function Hospitalized for Heart Failure: A Report From the OPTIMIZE-HF Registry
J. Am. Coll. Cardiol.,
August 21, 2007;
50(8):
768 - 777.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. C. Fonarow, W. F. Peacock, C. O. Phillips, M. M. Givertz, M. Lopatin, and for the ADHERE Scientific Advisory Committee and I
Admission B-Type Natriuretic Peptide Levels and In-Hospital Mortality in Acute Decompensated Heart Failure
J. Am. Coll. Cardiol.,
May 15, 2007;
49(19):
1943 - 1950.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Gheorghiade and G. C. Fonarow
Systolic Blood Pressure and Outcomes in Patients Hospitalized With Acute Heart Failure--Reply
JAMA,
February 28, 2007;
297(8):
808 - 809.
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. M. Kessler
Examining the Concept of Preserved Systolic Function
J. Am. Coll. Cardiol.,
December 19, 2006;
48(12):
2599 - 2600.
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. E. Dostal and L. E. Watson
Understanding Diastolic Heart Failure With Preserved Ejection Fraction: Choosing the Right Model
Hypertension,
May 1, 2006;
47(5):
830 - 832.
[Full Text]
[PDF]
|
|
|
|
